Not a traditional drug phase: Cinnamon dressing for Malodorous Wounds (Chronic, Malignant or Infected Wounds)
This listing is written in technical language. The bullets below are the parts that matter if you are deciding whether to call the study team.
Official registry: https://clinicaltrials.gov/study/NCT05685628 · Assistance Publique - Hôpitaux de Paris · enrollment listed as 98
What this phase means
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
If you join, the listed intervention(s) are Cinnamon dressing, or Charcoal dressing. The registry lists allocation as randomized.
They plan to enroll about 98 people at 6 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Evaluation of the Quality of Life Induced by the Cinnamon Anti-odor Dressing in Patients With Malodorous Wounds: a Multicenter Randomized Controlled Trial
Interventions: Cinnamon dressing, Charcoal dressing
Primary outcome (registry wording): Wound-Qol
Who it is for (from inclusion criteria)
- Ages 18 Years to any
- Patient \>18 years of age with a smelly wound (discomfort \> 4/10 expressed by the patient);
- Predictive wound healing \>14 days (clinical judgement);
- Patient benefiting from a social security scheme (AME excluded)
- Patient, and curator if applicable, informed and having signed the consent form for participation in the study
Who the registry excludes
- Patient who has received a secondary charcoal or cinnamon dressing within the last 48 hours
- Patient with pressure ulcer stage 1 or 2
- Patient treated by metronidazole or antimicrobial for \< 3 days;
- Patient who cannot communicate his feelings;
- Patient with cinnamon allergy;
- Persons deprived of their liberty or under guardianship;
- Inability to submit to the medical follow-up of the trial for geographical, social, psychological or cognitive reasons
Public study contact (from the registry)
Maxime CHERON, IDE
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
6 listed- Hôpital Henri Mondor — Créteil, France (recruiting)
- Hospitalisation à domicile Fondation Santé Service — Levallois-Perret, France (not_yet_recruiting)
- Hospitalisation à Domicile AP-HP — Paris, France (recruiting)
- Institut Curie — Paris, France (recruiting)
- Hôpital Sainte Périne — Paris, France (active_not_recruiting)
- Hospitalisation à domicile de la région de Melun — Vaux-le-Pénil, France (not_yet_recruiting)
FAQ about this NCT record
Is NCT05685628 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT05685628?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT05685628?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary